https://www.oncologynurseadvisor.com Mon, 07 Oct 2019 18:29:28 +0000 en-US hourly 1 https://wordpress.org/?v=6.4.3 https://www.oncologynurseadvisor.com/wp-content/uploads/sites/13/2024/01/cropped-CTA-ONA-HEM-favicon-32x32.png https://www.oncologynurseadvisor.com 32 32 https://www.oncologynurseadvisor.com/home/hot-topics/side-effect-management/recognition-and-diagnosis-of-cipn-in-cancer-patients-can-prevent-falls-and-injuries/ Wed, 02 Oct 2019 19:21:34 +0000 https://www.oncologynurseadvisor.com/?p=68282 A literature review identified CIPN as a potential contributor to falls and injuries in patients with cancer; however, evidence-based methods for preventing falls in these patients are scarce.]]> https://www.oncologynurseadvisor.com/home/headlines/conference-coverage/esmo-2019/comparison-study-of-clinical-benefit-and-price-of-cancer-drugs-in-us-and-europe/ Sun, 29 Sep 2019 18:53:20 +0000 https://www.oncologynurseadvisor.com/?p=68156 Researchers report on a study comparing the US cost and clinical benefit of recently approved cancer drugs with those in Europe.]]> https://www.oncologynurseadvisor.com/home/headlines/conference-coverage/esmo-2019/low-dose-aspirin-use-associated-with-reduced-risk-for-gastric-and-esophageal-cancers/ Sun, 29 Sep 2019 18:47:57 +0000 https://www.oncologynurseadvisor.com/?p=68153 Researchers present study findings that demonstrate the association between low-dose aspirin and risk for gastric or esophageal cancer at ESMO Congress 2019.]]> https://www.oncologynurseadvisor.com/home/headlines/conference-coverage/esmo-2019/pilot-program-of-shows-nurse-led-consultations-for-gyn-cancers-is-feasible/ Sun, 29 Sep 2019 18:21:16 +0000 https://www.oncologynurseadvisor.com/?p=68150 A pilot program investigated the value of systematic nurse-led consultations in lieu of physician-led consultations for both patients with gynecologic cancers and the nurse specialist consultants.]]> https://www.oncologynurseadvisor.com/home/headlines/conference-coverage/esmo-2019/new-data-on-hrqol-for-pts-with-hcc-from-keynote-240/ Sun, 29 Sep 2019 17:36:03 +0000 https://www.oncologynurseadvisor.com/?p=68148 Analysis of a cohort from the KEYNOTE-240 trial showed that health-related quality of life for patients with HCC was similar across the 2 arms of the study.]]> https://www.oncologynurseadvisor.com/home/headlines/conference-coverage/esmo-2019/app-offers-improved-cancer-and-self-care-and-communication-with-care-team/ Sun, 29 Sep 2019 17:04:10 +0000 https://www.oncologynurseadvisor.com/?p=68146 Swedish researchers report on an app that facilitates symptom management, self-care, and communication with the cancer care team.]]> https://www.oncologynurseadvisor.com/home/headlines/conference-coverage/esmo-2019/recognizing-acute-stressors-that-may-precipate-suicide-in-pts-with-metastatic-cancer/ Sun, 29 Sep 2019 16:56:30 +0000 https://www.oncologynurseadvisor.com/?p=68144 Emergency room admissions and reports of negative prognoses should prompt suicide prevention measures, according to results presented at ESMO Congress 2019.]]> https://www.oncologynurseadvisor.com/home/headlines/conference-coverage/esmo-2019/early-stage-still-important-prognostic-indicator-in-nonmetastatic-male-breast-cancer/ Sun, 29 Sep 2019 16:48:25 +0000 https://www.oncologynurseadvisor.com/?p=68142 A meta-analysis of 222 men with nonmetastatic male breast cancer confirmed that disease stage at diagnosis remains an important prognostic factor.]]> https://www.oncologynurseadvisor.com/home/headlines/conference-coverage/esmo-2019/gvs-validated-for-managing-older-pts-with-ovarian-cancer/ Sun, 29 Sep 2019 16:34:46 +0000 https://www.oncologynurseadvisor.com/?p=68140 Results of an analysis that validated the use of the GVS to determine vulnerability in older patients with ovarian cancer.]]> https://www.oncologynurseadvisor.com/home/headlines/conference-coverage/esmo-2019/qol-often-lower-for-crc-survivors-than-for-survivors-of-other-cancers/ Sat, 28 Sep 2019 20:07:22 +0000 https://www.oncologynurseadvisor.com/?p=68135 Although cancer survivors report positive quality of life outcomes, patients with colorectal cancer tend to report dissatisfaction with their quality of life and at least one survivorship issue.]]>